Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Announces New Direction For COVID-19 Policy In Annual Address

Executive Summary

Proposals in the speech that could affect the device industry include “one-stop shops” for COVID-19 testing and treatment, additional funding to stockpile tests and masks, and a new government center devoted to health care research.

You may also be interested in...



Industry to Biden: Count Us In On Cancer Moonshot

AdvaMed says the medtech industry needs to at the table to advise the government on investments that could lead to future cancer diagnostics and treatments.

US Postal Service To Distribute Biden’s Free COVID-19 Rapid Antigen At-Home Tests Starting This Week

Americans can order up to four rapid antigen tests per household through the USPS website now, or a phone hotline soon. The administration is working to buy another half a billion tests in the near future.

For Second Time This Month, Medtronic Announces Class I FDA Recall Related To HeartWare System Component

Medtronic, Baxter and BD are all facing recalls, with Medtronic finding yet another issue with HeartWare HVAD systems. Separately, the FDA put a Baxter respiratory device recall into Class I, and BD announced a recall on intraosseous devices.

Topics

Latest News
UsernamePublicRestriction

Register

MT145143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel